GlaxoSmithKline and Valeant Pharmaceuticals announce worldwide collaboration agreement
- Details
- Category: GlaxoSmithKline
![GlaxoSmithKline (GSK) GlaxoSmithKline (GSK)](http://www.worldpharmanews.com/images/stories/logo/gsk.gif)
Bristol-Myers Squibb and Pfizer Provide Update on Apixaban Clinical Development Program
- Details
- Category: Bristol-Myers Squibb
![Pfizer Inc Pfizer Inc](http://www.worldpharmanews.com/images/stories/logo/pfizer_b.gif)
ADAGIO trial results show Azilect® slows progression of Parkinson's disease
- Details
- Category: Lundbeck
![H. Lundbeck A/S H. Lundbeck A/S](http://www.worldpharmanews.com/images/stories/logo/lundbeck.gif)
Brings complementary capabilities in India to address patient populations most at risk
- Details
- Category: Genzyme
![Genzyme Corp. Genzyme Corp.](http://www.worldpharmanews.com/images/stories/logo/genzyme.gif)
Alpharma Responds To Unsolicited Proposal By King Pharmaceuticals, Inc.
- Details
- Category: Financial
Alpharma, Inc. (NYSE: ALO), a global specialty pharmaceutical company, confirmed that it received an unsolicited, non-binding proposal from King Pharmaceuticals, Inc. (NYSE: KG) to acquire all of the outstanding shares of Alpharma for $33.00 per share in cash. Alpharma said that proposal was identical in all material respects to two prior proposals made privately by King to the company.
King Proposes Acquisition of Alpharma for $33 Per Share in Cash
- Details
- Category: Financial
King Pharmaceuticals, Inc. (NYSE: KG) announced that it has submitted to the Board of Directors of Alpharma Inc. (NYSE: ALO) a proposal to acquire all of the outstanding shares of common stock of Alpharma for $33.00 per share in cash. The proposal is not conditioned on financing.
New Trial to Evaluate Nexavar® as Adjuvant Therapy in Liver Cancer
- Details
- Category: Bayer
![The Bayer Group The Bayer Group](http://www.worldpharmanews.com/images/stories/logo/bayer.gif)
More Pharma News ...
- Novo Nordisk joins the Call to Action for gender equality
- DAIICHI SANKYO continues its expansion in Germany and Europe
- Bristol-Myers Squibb and PDL BioPharma Enter Global Alliance
- Nycomed - strong results in second quarter 2008
- Divestment of four Roche pharmaceutical products to Meda
- AstraZeneca and Abbott Expand Relationship to Include Co-Promotion of CRESTOR®
- Teva Reports Second Quarter 2008 Results - Record Quarterly Sales of $2,823 Million